Typhlitis as a presenting manifestation of acute myelogenous leukemia.
We describe a case of typhlitis with onset before diagnosis of acute myelogenous leukemia or initiation of chemotherapy. Typhlitis is usually seen as a complication of chemotherapy for hematologic malignancies. It is being reported with increasing frequency in association with other disease states that produce profound neutropenia.
D'Souza
S
S
Department of Internal Medicine, University of Connecticut Health Center, Farmington, USA.
Lindberg
M
M
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007077:Ileal Diseases / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000601:surgery; D007813:Laparotomy; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor